Turn Therapeutics (TTRX) Cash from Investing Activities (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly Cash from Investing Activities of -$12227.0 in Q1 2026, up 61.11% quarter-over-quarter from -$31441.0 in Q4 2025.
Turn Therapeutics (TTRX) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Turn Therapeutics' Cash from Investing Activities history runs 3 years deep, the most recent figure standing at -$12227.0 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 579,519.10 |
| 10 | Turn Therapeutics | 175.38 Mn | 175.38 Mn | - | -12,227.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,227.00 |
| Mar 31, 2026 | -12,227.00 |
| Dec 31, 2025 | -31,441.00 |
| Dec 31, 2025 | -31,441.00 |
| Dec 31, 2024 | -7,842.00 |
| Dec 31, 2024 | -7,842.00 |